Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Filed Mar 28, 2025 · 10-K · 87 days after period end · 0001641172-25-001190
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$1.42M | -$1.17M | $12.36M | -$33.56K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 28, 2025 · 87 d after period end
